Asthma

Patients who have frequent asthma exacerbations are at greater risks for cumulative doses of corticosteroids, multiple comorbidities and mortality, according to a poster presented at the European Respiratory Society International Congress.

Patients with different asthma severity regularly used a home device for measuring fractional exhaled nitric oxide for 12 weeks as part of their asthma management strategies, according to a poster presentation here.

Metered-dose inhalers had higher estimated greenhouse gas emissions than dry-powder and soft-mist inhalers but cost less than these propellant-free inhalers, according to a research letter published in JAMA.

Odds for asthma symptoms, COPD and chronic bronchitis went up if individuals reported earlier “often/always” vs. “never” gum bleeding, according to a poster presented at the European Respiratory Society International Congress.

Risks for respiratory viral infections increased among children with asthma who were exposed to high levels of floor cockroach and mouse airborne allergens, according to a study published in The Journal of Allergy and Clinical Immunology.

The next time you have patients who struggle with airway resistance, you may want to refer them to your local periodontist for a deep cleaning, according to a poster presented at the European Respiratory Society International Congress.

Asthma increased the need for respiratory support in COVID-19 patients, whereas metabolic syndrome raised the risk for severe COVID-19, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Adults with asthma and/or COPD who received 23 text messages about preventer inhaler use over 26 weeks had improved inhaler adherence, according to a poster presented at the European Respiratory Society International Congress.

Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress.

Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress.